Combined Off-Pump Coronary Revascularization and Lung Resection

Köksal, Cengiz; Sarikaya, Sabit; Zengin, Mustafa; Atasalihi, Ali

doi:10.14712/18059694.2019.67

Cited by 6 publications

(14 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The decreased "vigilance" of the immune system induced after the use of ECC can enhance tumor growth and accelerate its dissemination via the lymphatic system (18). It would be optimal to perform cardio-surgical procedures in patients with simultaneous lung cancer without the need of ECC, but that is possible in some patients who are scheduled for coronary surgery (19). Theoretically, the optimal solution, after taking in consideration the above mentioned, is to perform lung resection and subsequently cardiac surgery in the second period.…”

Section: Table 5 Postoperative Outcome Of Complications and Mortalitymentioning

confidence: 99%

Combined surgical treatment of lung cancer and heart diseases

Kovacicova¹,

Omran²,

Mand'ák³

2014

BLL

View full text Add to dashboard Cite

Objective: The co-incidence of lung cancer and heart disease is increasing. This can be caused by population ageing, which has more co-morbidities and most likely due to the common etiological causes of both entities, i.e. smoking, hypertension and obesity. The aim of this study was to analyze the outcomes of simultaneously performed heart surgery and pulmonary resection in a selected group of patients. Methods: From January 2002 to December 2011 we performed in our department 1115 pulmonary resections for lung tumor. Signifi cant heart disease requiring surgical treatment was diagnosed in 21 patients from the whole group. In 12 patients, group A; simultaneous heart surgery and lung resection procedure were performed. Results: Group A consisted of 8 men and 4 women with the median age of 67.8 ± 5.9 years. In this group, 10 lobectomy procedures and 2 wedge resections for pulmonary metastasis were done. Nine patients underwent coronary artery revascularization, 2 patients underwent mitral valve replacement and one patient underwent tumor removal from the left atrium. In 5 patients, extracorporeal circulation (ECC) was needed, the remaining 7 patients underwent myocardial revascularization using an off-pump technique. Group B consisted of 7 men and 5 women with the age of 68.5 ± 7.4 years. Ten lobectomy procedures and 2 wedge resections were performed. Conclusion: The risk of simultaneously performed lung resection and cardiac surgery is not high. Despite the certain differences in clinical indicators between group A and B, the safety of simultaneous procedure, in group A, was evident. Furthermore, earlier lung resection was enabled and the eventual complications from further surgical procedure were avoided (Tab. 5, Ref. 33). Text in PDF www.elis.sk. Acknowledgement: Supported by the programme PRVOUK P37/04. DyszkiewiczW, Jemielity M, Piwkowski C, Kasprzyk M, Perek B, Gasiorowski L, Kaczmarek E. The early and late results of combined off pump coronary artery bypass grafting and pulmonary resection in patients with concomitantlung cancer and unstable coronary heart disease. Eur J Cardiothorac Surg 2008; 34: 531-535. 32. Apostolakis E, Prokakis C, Koletsis E, Dougenis D. Median sternotomy for combined coronary artery bypass grafting and lung tumor resection: is it valid or not? Eur J Cardiothorac Surg 2009; 35: 1117-1119. 33. Habal P, Šimek J, Lonský V, Novotný J. Possibilities of combined surgical treatment of lung tumours and heart diseases Acta Medica (Hradec Králové) 2006; 49 (3): 175-181.

show abstract

Section: Table 5 Postoperative Outcome Of Complications and Mortalitymentioning

confidence: 99%

Combined surgical treatment of lung cancer and heart diseases

Kovacicova¹,

Omran²,

Mand'ák³

2014

BLL

View full text Add to dashboard Cite

show abstract

“…3. Considering the above mentioned reasons, some departments try to cover both of the systems together using the surgical therapy (6,10,18). The possibilities of surgical approach in combined disease of the heart and lungs are various.…”

Section: Discussionmentioning

confidence: 99%

“…The psychological effect is certainly essential for the patients who know about the tumorous proliferation and are waiting for the therapy. Another medical advantage is the possibility to avoid the effects of the cardiopulmonary bypass on the organism suffering from oncological disease (8,16,18,19). An indisputable advantage of median sternotomy is the possibility to perform bilateral mediastinal lymphadenectomy, which is important not only for the therapy, but for the prognosis.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Possibilities of Combined Surgical Treatment of Lung Tumours and Heart Diseases

Habal

Šimek

Lonský

et al. 2006

Acta Med. (Hradec Kralove, Czech Repub.)

View full text Add to dashboard Cite

The purpose of the study was a retrospective evaluation of the outcome of surgical therapy of lung cancer in patients where there was concomitant cardiac disease and who underwent a cardiac operation either because of ischemic heart disease or because of valvular disease. These patients were operated on at various time intervals (two to ten months) after their cardiac operation. Some patients had their lung cancer surgery after the cardiac operation because of the high risk of possible cardiac postoperative complications; in one patient the lung operation preceded the cardiac one.

show abstract

“…The incidence of mortality and morbidity varied with each technique. Patients who underwent off-pump bypass had a 0% mortality 30,[32][33][34][35][38][39][40]42,55,57 and 0% to 48% morbidity 30,[32][33][34][35]39,40,42,55 in comparison to 0% to 20.8% and 0% to 67% among patients who underwent conventional bypass, respectively. 22 24 10 CCAB 5 (56%) -Takahashi T, et al (1995) 27 19 CCAB -5 (26%) Rao V, et al (1996) 28 24 CCAB 1 (4.5%) -Voets AJ, et al (1997) 51 34 CCAB 5 (18%) - Danton MHD, et al (1998) 29 Patients who underwent off-pump technique were found to be associated with lower incidence of blood loss, re-exploration for bleeding, cardiac and pulmonary complications, tumor recurrence, and death.…”

Section: Conventional/off-pump Bypassmentioning

confidence: 99%

Surgical Management of Coronary Artery Disease Associated with Malignancy

Darwazah¹

2012

Journal of Cardiac Surgery

View full text Add to dashboard Cite

Surgical management of patients with combined coronary artery disease and malignancy remains a challenge. In this review the time of surgical intervention, whether to treat the malignancy or the coronary artery disease first, and which bypass technique should be used during myocardial revascularization are reviewed to determine the most optimal strategy to manage patients who require coronary surgical revascularization and present with an underlying malignancy.

show abstract

Combined Off-Pump Coronary Revascularization and Lung Resection

Cited by 6 publications

References 7 publications

Combined surgical treatment of lung cancer and heart diseases

Combined surgical treatment of lung cancer and heart diseases

Possibilities of Combined Surgical Treatment of Lung Tumours and Heart Diseases

Surgical Management of Coronary Artery Disease Associated with Malignancy

Contact Info

Product

Resources

About